Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sol Klioze"'
Autor:
Gary G. Koch, Daniel O. Koralek, Robert A. Wise, Michael B. Bracken, Roger B. Cohen, Sol Klioze, William T. Duggan, Jackson Neville Colin, Joanna Lem, Nicolle M. Gatto
Publikováno v:
Diabetes care. 42(9)
OBJECTIVEThe Follow-Up Study of patients previously enrolled in Exubera controlled clinical trials (FUSE) was designed to evaluate whether patients previously treated with Exubera (EXU; insulin human [rDNA origin], inhaled powder) in controlled clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cd145d5499713efe8b88638a14518e7
https://pubmed.ncbi.nlm.nih.gov/31331907
https://pubmed.ncbi.nlm.nih.gov/31331907
Publikováno v:
Diabetes Care. 30:2508-2510
Weight gain is commonly seen when patients are started on subcutaneous (SC) insulin. In the UK Prospective Diabetes Study, those assigned insulin gained 4 kg more than those assigned conventional therapy at 10 years (1). Given that the majority of pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c60a680b04dd7b37141c349f6c77636
https://doi.org/10.2337/dc06-2083
https://doi.org/10.2337/dc06-2083
Autor:
Joann Reis, Julio Rosenstock, Sol Klioze, William T. Cefalu, William T. Duggan, Priscilla Hollander
Publikováno v:
Diabetes technologytherapeutics. 11(11)
Objective This study assessed pulmonary safety following discontinuation and readministration of inhaled human insulin {Exubera [EXU] [Pfizer Inc., New York, NY] (insulin human [recombinant DNA origin]) inhalation powder} in adults with type 2 diabet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc0e5ae22a6a701baf88856389d218fa
https://pubmed.ncbi.nlm.nih.gov/19905885
https://pubmed.ncbi.nlm.nih.gov/19905885
Autor:
Jay S. Skyler, William T. Duggan, Lois Jovanovic, Priscilla Hollander, Alan S. Krasner, Pamela F. Schwartz, R. Riese, Sol Klioze, Joann Reis
Publikováno v:
Diabetes research and clinical practice. 82(2)
Objective To assess pulmonary safety during discontinuation and readministration of inhaled human insulin (EXU; Exubera ® insulin human [rDNA origin]) Inhalation Powder) therapy in adults with type 1 diabetes. Methods Patients were randomized to rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26c526acfbf07186c8d2268bc61a0257
https://pubmed.ncbi.nlm.nih.gov/18824271
https://pubmed.ncbi.nlm.nih.gov/18824271
Publikováno v:
Diabetes care. 30(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8cb56e44eb3457566406ec9c6436f192
https://pubmed.ncbi.nlm.nih.gov/17536080
https://pubmed.ncbi.nlm.nih.gov/17536080